Perspective on the future standard of care for second-line treatment for patients with R/R LBCL
In this MEDtalk, Alexander Fosså, MD, PhD, Consultant, Department of Oncology, Oslo University Hospital, gives his perspective on CAR-T cell therapy for patients with relapsed/refractory large B-cell lymphoma.